Abiopharma

Net Asset Value(s)

Agenus Inc. - Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized

Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold

Jiuzi Holdings and AetheriumX Sign Strategic MOU for $30M Investment into Web3

A Message from Our Chief Executive Officer

Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26

Quipt Home Medical Completes the Previously Announced Arrangement With Affiliates of Kingswood and Forager

Flowserve Appoints Brian Savoy to Board of Directors

Ferguson Files Definitive Proxy Materials and Transition Report

Streamex Corp. Appoints Christine Plummer, Former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial Officer